Transcriptional regulation of MICA and MICB: A novel polymorphism in MICB promoter alters transcriptional regulation by Sp1

European Journal of Immunology

Volumn 37, Issue 7, 2007, Pages 1938-1953

  Rodríguez Rodero, Sandra ^a   González, Segundo ^b   Rodrigo, Luis ^a   Fernández Morera, Juan L ^a   Martínez Borra, Jesús ^a   López Vázquez, Antonio ^a   López Larrea, Carlos ^a  

^a HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^b DEPARTAMENTO DE BIOQUÍMICA Y BIOLOGÍA MOLECULAR   (Spain)

Author keywords

MICA; MICB; NKG2D; Promoter polymorphism

Indexed keywords

ADENINE; CCAAT ENHANCER BINDING PROTEIN; COMPLEMENTARY DNA; CYTOSINE; GUANINE; LUCIFERASE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1A; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1B; NUCLEAR FACTOR Y; TRANSCRIPTION FACTOR SP1; TRANSCRIPTION FACTOR SP3; TRANSCRIPTION FACTOR SP4; UNCLASSIFIED DRUG;

5' UNTRANSLATED REGION; ANTIGEN EXPRESSION; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CONTROLLED STUDY; GC RICH SEQUENCE; GENE DELETION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INFECTION RESISTANCE; INNATE IMMUNITY; MALIGNANT TRANSFORMATION; MOLECULAR GENETICS; NUCLEIC ACID BASE SUBSTITUTION; POPULATION GENETICS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PROTEIN INTERACTION; SINGLE NUCLEOTIDE POLYMORPHISM; SPAIN; TRANSCRIPTION INITIATION SITE; TRANSCRIPTION REGULATION;

BASE SEQUENCE; CACO-2 CELLS; ELECTROPHORETIC MOBILITY SHIFT ASSAY; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HELA CELLS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IMMUNOPRECIPITATION; MOLECULAR SEQUENCE DATA; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); RECEPTORS, IMMUNOLOGIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SP1 TRANSCRIPTION FACTOR; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRANSFECTION;

EID: 34447535179     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200737031     Document Type: Article

References (80)

1. Cerwenka, A. and Lanier, L. L., Natural killer cells, viruses and cancer. Nat. Rev. Immunol. 2001. 1: 41-49.
2. Raulet, D. H., Roles of the NKG2D immunoreceptor and its ligands. Nat. Rev. Immunol. 2003. 3: 781-790.
3. Diefenbach, A., Hsia, J. K., Hsiung, M. Y. and Raulet, D. H., A novel ligand for the NKG2D receptor activates NK cells and macrophages and induces tumor immunity. Eur. J. Immunol. 2003. 33: 381-391.
4. Groh, V., Bahram, S., Bauer, S., Herman, A., Beauchamp, M. and Spies, T., Cell stress-regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium. Proc. Natl. Acad. Sci. USA 1996. 93: 12445-12450.
5. Bahram, S., Bresnahan, M., Geraghty, D. E. and Spies, T., A second linage of mammalian major histocompatibility complex class I genes. Proc. Natl. Acad. Sci. USA 1994. 91: 6259-6263.
6. Cosman, D., Mullberg, J., Sutherland, C. L., Chin, W., Armitage, R., Fanslow, W., Kubin, M. and Chalupny, N. J., ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor. Immunity 2001. 14: 123-133.
7. Radosavljevic, M., Cuillerier, B., Wilson, M. J., Clement, O., Wicker, S., Gilfillan, S., Beek, S. et al., A cluster of ten novel MHC class I related genes on human chromosome 6q24.2-q25.3. Genomics 2002. 79: 114-123.
8. Jan Chalupny, N., Sutherland, C. L., Lawrence, W. A., Rein-Weston, A. and Cosman, D., ULBP4 is a novel ligand for human NKG2D. Biochem. Biophys. Res. Commun. 2003. 305: 129-135.
9. Bacon, L., Eagle, R. A., Meyer, M., Easom, N., Young, N. T. and Trowsdale, J., Two human ULBP/RAET1 molecules with transmembrane regions are ligands for NKG2D. J. Immunol. 2004. 173: 1078-1084.
10. Bahram, S., Inoko, H., Shiina, T. and Radosavljevic, M., MIC and other NKG2D ligands: from none to too many. Curr. Opin Immunol. 2005. 17: 505-509.
11. Marsh, S. G., Albert, E. D., Bodmer, W. F., Bontrop, R. E., Dupon, B., Erlich, H. A., Geraghty, D. E. et al., Nomenclature for factors of the HLA system, 2004. Tissue Antigens 2005. 65: 301-369.
12. Groh, V., Steinle, A., Bauer, S. and Spies, T., Recognition of stress induced MHC molecules by intestinal ephitelial γδT cells. Science 1998. 279: 1737-1740.
13. Zou, Y., Bresnahan, W., Taylor, R. T. and Stastny, P., Effect of human cytomegalovirus on expression of MHC class I-related chains A. J. Immunol. 2005. 174: 3098-3104.
14. Azimi, N., Jacobson, S., Tanaka, Y., Corey, L., Groh, V. and Spies, T., Immunostimulation by induced expression of NKG2D and its MIC ligands in HTLV-1 associated neurologic disease. Immunogenetics 2006. 58: 252-258.
15. Xu, X., Rao, G., Gaffud, M. J., Ding, H. G., Maki, G., Klingemann, H. G., Groh, V. et al., Clinicopathological significance of major histocompatibility complex class I-related chain A and B expression in thyroid cancer. J. Clin. Endocrinol. Metab. 2006. 91: 2704-2712.
16. Gasser, S., Orsulic, S., Brown, E. J. and Raulet, D. H., The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor. Nature 2005. 436: 1186-1190.
17. Das, H., Groh, V., Kujil, C., Sugita, M., Morita, C. and Spies, T., MICA engagement by human Vγ2Vδ2 T cells enhances their antigen-dependent effector function. Immunity 2001. 15: 83-93.
18. Groh, V., Rhinehart, R., Randolph-Habecker, J., Topp, M. S., Riddell, S. R. and Spies, T., Costimulation of CD8 αβ Tcells by NKG2D via engagement by MIC induced on virus-infected cells. Nat. Immunol. 2001. 2: 255-260.
19. Bauer, S., Groh, V., Wu, J., Steinle, A., Phillips, J. H., Lanier, L. L. and Spies, T., Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA Science 1999. 285: 727-729.
20. Watson, N. F., Spendlove, I., Madjd, Z., McGilvray, R., Green, A. R., Ellis, I. O., Scholefield, J. H. et al., Expression of the stress-related MHC class I chain-related protein MICA is an indicator of good prognosis in colorectal cancer patients. Int. J. Cancer 2006. 118: 1445-1452.
21. Raffaghello, L., Prigione, I., Airoldi, I., Camoriano, M., Levreri, I., Gambini, C., Pende, D. et al., Downregulation and/or release of NKG2D ligands as immune evasion strategy of human neuroblastoma. Neoplasia 2004. 6: 558-568.
22. Roberts, A. I., Lee, L., Schwartz, E., Groh, V., Spies, T., Ebert, E. C. and Jabri, B., NKG2D receptors induced by IL-15 costimulate CD28-negative effector CTL in the tissue microenviroment. J. Immunol. 2001. 167: 5527-5530.
23. Meresse, B., Chen, Z., Ciszewski, C., Tretiakova, M., Bhagat, G., Krausz, T. N., Raulet, D. H. et al., Coordinated Induction by IL-15 of a TCR-independent pathway converts CTL into lymphokine-activated killer cells in celiac disease. Immunity 2004. 21: 357-366.
24. Gonzalez, S., Rodrigo, L., López-Vazquez, A., Fuentes, D., Agudo-Ibañez, L., Rodríguez-Rodero, S., Fdez-Morera, J. L. et al., Association of MHC class I related gene B (MICB) to celiac disease. Am. J. Gastroenterol. 2004. 99: 676-680.
25. Barker, J. M., Clinical review: Type 1 diabetes-associated autoimmunity: natural history, genetic associations, and screening. J. Clin. Endocrinol. Metab. 2006. 91: 1210-1217.
26. Gonzalez, S., Rodríguez-Rodero, S., Martínez-Borra, J., López-Vazquez, A., Rodrigo, L. and López-Larrea, C., MICB typing by PCR amplification with sequence specific primers. Immunogenetics 2003. 54: 850-855.
27. Ando, H., Mizuki, H., Ota, M., Yamazaki, M., Ohno, S., Goto, K., Miyata, Y. et al., Allelic variants of the human MHC class I chain related B gene (MICB). Immunogenetics 1997. 46: 499-508.
28. Mantovani, R., The molecular biology of the CCAAT-binding factor NF-Y. Gene 1999. 239: 15-27.
29. Blume, S. W., Snyder, R. C., Ray, R., Thomas, S., Koller, C. A. and Miller, D. M., Mithramycin inhibits SP1 binding and selectively inhibits transcriptional activity of the dihydrofolate reductase gene in vitro and in vivo. J. Clin. Invest. 1991. 88: 1613-1621.
30. Zhou, Y. and Lee, A. S., Mechanism for the suppression of the mammalian stress response by genistein, an anticancer phytoestrogen from soy. J. Natl. Cancer Inst. 1998. 90: 381-388.
31. Sharina, I. G., Martin, E., Thomas, A., Uray, K. L., and Murad, F., CCAAT-binding factor regulates expression of the beta1 subunit of soluble guanylyl cyclase gene in the BE2 human neuroblastoma cell line. Proc. Natl. Acad. Sci. USA. 2003. 100: 11523-11528.
32. Sowa, Y., Orita, T., Hiranabe-Minamikawa, S., Nakano, K., Mizuno, T., Nomura, H. and Sakai, T.Histone deacetylase inhibitor activates the p21/WAF1/Cip1 gene promoter through the Sp1 sites. Ann. N Y Acad. Sci. 1999. 886: 195-199
33. Diefenbach, A., Jensen, E. R., Jamieson, A. M. and Raulet, D. H., Rae1 and H60 ligands of the NKG2D receptor stimulate tumor immunity. Nature 2001. 413: 165-171.
34. + T cell pathway. J. Immunol. 2004. 172: 757-761.
35. Groh, V., Rhinehart, R., Secrist, H., Bauer, S., Grabstein, K. H. and Spies, T., Broad tumor-associated expression and recognition by tumor-derived gamma delta T cells of MICA and MICB. Proc. Natl. Acad. Sci. USA 1999. 96: 6879-6884.
36. Vetter, C. S., Groh, V., thor Straten, P., Spies, T., Brocker, E. B. and Becker, J. C., Expression of stress-induced MHC class I related chain molecules on human melanoma. J. Invest. Dermatol. 2002. 118: 600-605.
37. Smyth, M. J., Swann, J., Cretney, E., Zefara, N., Yokoyama, W. M. and Hayakawa, Y., NKG2D function protects the host from tumor initiation. 2005 J. Exp. Med.. 202: 583-588.
38. Cerwenka, A., Baron, J. L. and Lanier, L., Ectopic expression of retinoic acid early inducible-1 gene (RAE-1) permits natural killer cell-mediated rejection of a MHC class I-bearing tumor in vivo. Proc. Natl. Acad. Sci. USA 2001. 98: 11521-11526.
39. Bannwarth, S., Lainé, S., Daher, A., Grandvaux, N., Clerzius, G., LeBlanc, A. C., Hiscott, J. and Gatignol, A., Cell-specific regulation of TRBP1 promoter by NF-Y transcription factor in lymphocytes and astrocytes. J. Mol. Biol. 2006. 355: 898-910.
40. Bellorini, M., Lee, D. K., Dantonel, J. C., Zemzouzi, K., Roeder, R. G., Tora, L. and Mantovani, R., CCAAT binding NF-Y-TBP interactions: NF-YB and NF-YC require short domains adjacent to their histone fold motifs for association with TBP basic residues. Nucleic Acids Res. 1997. 25: 2174-2181.
41. Zhao, J., Bilsland, A., Hoare, S. F. and Ketih, W. N., Involvement of NF-Y and Sp1 binding sequences in basal transcription of the human telomerase RNA gene. FEBS Lett. 2003. 536: 111-119.
42. Roder, K., Wolf, S. S., Larkin, K. J. and Schweizer, M., Interaction between the two ubiquitously expressed transcription factors NF-Y and Sp1. Gene 1999. 234: 61-69.
43. González, S., Groh, V. and Spies, T., Immunobiology of human NKG2D and its ligands. Curr. Top. Microbiol. Immunol. 2006. 298: 121-138.
44. Blake, M. C., Jambou, R. C., Swick, A. G., Kahn, J. W. and Azizkhan, J. C., Transcriptional initiation is controlled by upstream GC box interaction in a TATA-less promoter. Mol. Cell. Biol. 1990. 10: 6632-6641.
45. Morgan, W. D., Transcription factor Sp1 binds to and activates a human hsp70. Mol. Cell. Biol. 1989. 9: 4099-4104.
46. Morgan, W. D, Williams, G. T., Morimoto, R. I., Greene, J., Kingston, R. E. and Tjian, R., Two transcriptional activators, CCAAT-box-binding transcription factor and heat shock transcription factor, interact with a human hsp70 gene promoter. Mol. Cell. Biol. 1987. 7: 1129-1138.
47. Kabe, Y., Yamada, J., Uga, H., Yamaguchi, Y., Wada, T. and Handa, H., NF-Y is essential for the recruitment of RNA polymerase II and inducible transcription of several CCAAT box-containing genes. Mol. Cell. Biol. 2005. 25: 512-522.
48. Caretti, G., Salsi, V., Vecchi, C., Imbriano, C. and Mantovani, R., Dynamic recruitment of NF-Y and histone acetyltransferases on cell-cycle promoters. J. Biol. Chem. 2003. 278: 30435-30440.
49. Sabacki, T., Sobocka, M. B., Babinska, A., Ehrlich, Y. H., Banerjee, P. and Kornecki, E., Genomic structure, organization and promoter analysis of the human F11R/F11 receptor/junctional adhesion molecule-1/ JAM-A. Gene 2006. 366: 128-144.
50. Suske, G., The Sp-family of transcription factors. Gene 1999. 238: 291-300.
51. López-Soto, A., Quiñones-Lombraña, A., López-Arbesú, R., López-Larrea, C. and Gonzalez, S., Transcriptional regulation of ULBP1, a human ligand of the NKG2D receptor. J. Biol. Biochem. 2006. 281: 30419-30430.
52. Wang, L., Wei, D., Huang, S., Peng, Z., Le, X., Wu, T. T., Yoo, J. et al., Transcription factor Sp1 expression is a significant predictor of survival in human gastric cancer. Clin. Cancer Res. 2003. 9: 6371-6380.
53. Hosoi, Y., Watanabe, T., Nakagawa, K., Matsumoto, Y., Enomoto, A., Morita, A., Nagawa, H. and Suzuki, N., Up-regulation of DNA-dependet protein kinase activity and Sp1 in colorectal cancer. Int. J. Oncol. 2004. 25: 461-468.
54. Xiao-Yan, L., van Huijsduijnen, R. H., Mantonavi, R., Benoist, C. and Mathis, D., Intron-exon organization of the NF-Y genes. Tissue-specific splicing modifies an activation domain. J. Biol. Chem. 1992. 267: 8984-8990.
55. Mantovani, R., Xiao-Yan, L., Pessara, U., van Huijsduijnen, R. H, Benoist, C. and Mathis, D., Dominant negative analogs of NF-YA. J. Biol. Chem. 1994. 269: 20340-20346.
56. Venkataraman, G. M., Suciu, D., Groh, V., Boss, J. M. and Spies, T., Promoter region architecture and transcriptional regulation of the genes for the MHC class I-related chain A and B ligands of NKG2D. J. Immunol. 2007. 178: 961-969.
57. Salih, H. R., Goehlsdorf, D. and Steinle, A., Release of MICB molecules by tumor cells: mechanism and soluble MICB in sera of cancer patients. Hum. Immunol. 2006. 67: 188-195.
58. Wu, J. D., Higgings, L. M., Steinle, A., Cosman, D., Haugk, K. and Plymate, S. R., Prevalent expression of the immunostimulatory MHC class I chain-related molecule is counteracted by shedding in prostate cancer. J. Clin. Invest. 2004. 114: 560-568.
59. Polette, M., Nawrocki-Raby, B., Gilles, C., Clavel, C. and Bimberaut, P., Tumor invasion and matrix metalloproteinases.. Crit. Rev. Oncol. Hematol. 2004. 49: 179-186.
60. Groh, V., Wu, J., Yee, C. and Spies, T., Tumor-derived soluble MIC ligands impair expression of NKG2D and T-cell activation. Nature 2002. 419: 734-738
61. Marten, A., von Lilienfeld-Toal, M., Buehler, M. W. and Schmidt, J., Soluble MIC is elevated in the serum of patients with pancreatic carcinoma diminishing gammadelta T cell cytotoxicity. Int. J. Cancer. 2006. 119: 2359-2365.
62. Rodríguez-Rodero, S., Rodrigo, L., Fdez-Morera, J. L., Martínez-Borra, J., López-Vázquez, A., Fuentes, D., López-Arbesu, R. et al., MHC class I chain-related gene B promoter polymorphisms and celiac disease. Hum. Immunol. 2006. 67: 208-214.
63. Price, P., Campbell, W., Allcock, R., Sayer, D., Garlepp, M., Kok, C. C., French, M. et al., The genetic basis for the association of the 8.1 ancestral haplotype (A1,B8,DR3) with multiple immunopathological diseases. Immunol. Rev. 1999. 167: 257-274.
64. Larsen, C. E. and Chester, A. A., The genetics of HLA-associated disease. Curr. Op. Immunol. 2004. 16: 660-667.
65. Thio, C. L., Thomas, D. L., Karacki, P., Gao, X., Marti, D., Kaslow, R. A., Goedert, J. J. et al. Comprehensive analysis of class I and class II HLA antigens and chronic hepatitis B virus infection. J. Virol. 2003. 77: 12083-12087.
66. McKiernan, S. M., Hagan, R., Curry, M., McDonald, G. S., Kelly, A., Nolan, N., Walsh, A. et al. Distinct MHC class I and II alleles are associated with hepatitis C viral clearance, originating from a single source. Hepatology 2004. 40: 108-114.
67. Flores-Villanueva, P. O., Hendel, H., Caillat-Zucman, S., Rappaport, J., Burgos-Tiburcio, A., Bertin-Maghit, S., Ruiz-Morales, J. A. et al., Associations of MHC ancestral haplotypes with resistance/ susceptibility to AIDS disease development. J. Immunol. 2003. 170: 1925-1929.
68. Hüe, J. M., Monteiro, R., Zhang, S., Cellier, C., Schmitz, J., Verkarre, V., Fodil, N. et al., A direct role for NKG2D/MICA interaction in villous atrophy during celiac disease. Immunity 2004. 21: 367-377.
69. Groh, V., Brühl, A., Nelson, J. L., El-Gabalawi, H. and Spies, T., Stimulation of T cell autoreactivity by anomalous expression of NKG2D and its MIC ligands in rheumatoid arthritis. Proc. Natl. Acad. Sci. USA 2003. 100: 9452-9457
70. López-Arbesú, R., Ballina-García, F. J., Alperi-López, M., López-Soto, A., Rodríguez-Rodero, S., Martínez-Borra, J., López-Vázquez, A. et al., MHC class I chain-related gene B (MICB) is associated with rheumatoid arthritis susceptibility. Rheumatology 2007. 46: 426-430.
71. Friese, M. A., Platte, M., Lutz, S. Z., Naumann, U., Aulwurm, S., Bischof, F., Buhring, H. J. et al., MICA/NKG2D-mediated immunogene therapy of experimental gliomas. Cancer Res. 2003. 63: 8996-9006.
72. Frohman, M. A., Dush, M. K. and Martin, G. R., Rapid production of full-length cDNA from rare transcripts: Amplification using a single gene-specific oligonucleotide primer. Proc. Natl. Acad. Sci. USA 1988. 85: 8998-9002.
73. González, S. and López-Larrea, C., Characterization of the human C6 promoter. Requirement of c/EBP binding site for C6 gene promoter activity. J. Immunol. 1996. 157: 2282-2290.
74. Stephens, H. A., Vaughan, R. W., Collins, R., Kondectis, E., Therod, J. and Payne, A., PCR-SSP phototyping of MICA alleles. Tissue Antigens 1999. 53: 167-174.
75. Wingender, E., Chen, X., Hehl, R., Karas, H., Liebich, L, Matys, V., Meinhardt, T. et al., TRANSFAC: an integrated system for gene expression regulation. Nucleic Acids Res. 2000. 28: 316-319.
76. Bradford, M. M., A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye-binding. Anal. Biochem. 1976. 72: 248-254.
77. Dingam, J., Labovitz, R. and Roeder, R. R., Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 1983. 11: 1475-1489.
78. Andrews, N. C. and Faller, D. V., A rapid micropreparation technique for extraction of DNA-binding proteins from limiting number of mammalian cells. Nucleic Acids Res. 1991. 19: 2499-2501.
79. Barath, P., Poliakova, D., Luciakova, K. and Nelson, B. D., Identification of NF-1 as a silencer protein of the human adenine nucleotide translocase-2 gene. Eur. J. Biochem. 2004. 271: 1781-1788.
80. Adams, B. S., Cha, H. C, Cleary, J., Haiying, T., Wang, H., Sitwala, K. and Markowitz, D. M., DEK binding to class II MHCY-box sequences is gene- and allele specific. Arthritis Res. Ther. 2003. 5: R226-R233.